Healthcare

But study shows risk was better than expected-so expanded-criteria organs might be 'only marginally worse' than standard

One drawback is shorter time to a patient's first vascular access intervention

When multiple sclerosis patients also have comorbid diabetes, their disability scores tend to be greater than those of MS patients who do not have the disease.

Main culprit is coagulase-negative Staphylococcus

Real-world outcomes with investigational drug still favourable

New treatment is effective in Canada and U.S., but not in rest of North America; epilepsy classification may have been a factor

The new drug safinamide might have some impact in preventing the involuntary movements characteristic of Parkinson's disease. However, it did not perform any better than placebo over a two-year period.

First-born more likely to be food-allergic than younger siblings